Research Article
The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients
Table 2
The HIF1-
expression according to clinicopathological features.
| | Average | Standard deviation | Minimum | Lower quartile | Median | Upper quartile | Maximum | |
| FIGO stage | | | | | | | | | IA | 6.31 | 3.30 | 0 | 4 | 6 | 9 | 12 | NS | IB | 6.82 | 2.74 | 3 | 4 | 6 | 9 | 12 | II | 5.14 | 1.46 | 3 | 4 | 6 | 6 | 8 | IIIA | 7.20 | 2.35 | 4 | 6 | 8 | 8 | 12 | IIIC | 5.65 | 3.10 | 0 | 4 | 6 | 8 | 12 | IVB | 4.33 | 2.34 | 0 | 4 | 5 | 6 | 6 | Grading | | | | | | | | | 1 | 5.86 | 3.48 | 2 | 4 | 4 | 9 | 12 | NS | 2 | 6.25 | 2.77 | 0 | 4 | 6 | 8 | 12 | 3 | 5.50 | 2.83 | 0 | 4 | 6 | 8 | 9 | Bokhman subtype | | | | | | | | | 1 | 5.56 | 2.29 | 0 | 4 | 6 | 6 | 12 | 0.0115 | 2 | 7.64 | 3.67 | 0 | 6 | 7 | 12 | 12 | Lymph node metastases | | | | | | | | | 0 | 6.30 | 2.77 | 0 | 4 | 6 | 8 | 12 | NS | 1 | 5.39 | 2.92 | 0 | 4 | 6 | 6 | 12 | Distant metastases | | | | | | | | | 0 | 6.19 | 2.82 | 0 | 4 | 6 | 8 | 12 | NS | 1 | 4.33 | 2.34 | 0 | 4 | 5 | 6 | 6 | Myometrial invasion 50% | | | | | | | | | 0 | 6.38 | 3.07 | 0 | 4 | 6 | 9 | 12 | NS | 1 | 5.57 | 2.33 | 0 | 4 | 6 | 6 | 12 | Cervical infiltration | | | | | | | | | 0 | 6.21 | 3.07 | 0 | 4 | 6 | 9 | 12 | NS | 1 | 5.87 | 2.46 | 0 | 4 | 6 | 8 | 12 | Infiltration of adnexa | | | | | | | | | 0 | 6.05 | 2.81 | 0 | 4 | 6 | 8 | 12 | NS | 1 | 6.18 | 3.03 | 0 | 4 | 6 | 8 | 12 | Risk of recurrence | | | | | | | | | Low | 4.90 | 2.15 | 0 | 4 | 5 | 6 | 9 | 0.0434 | Intermediate and high | 6.40 | 2.91 | 0 | 4 | 6 | 8 | 12 |
|
|